Feasibility and Acceptability of a Mobile App for Prolonged Grief Disorder Symptoms.
e-mental health
mobile app
prolonged grief disorder
self-monitoring intervention
Journal
Clinical psychology in Europe
ISSN: 2625-3410
Titre abrégé: Clin Psychol Eur
Pays: Germany
ID NLM: 9918266187206676
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
received:
19
12
2022
accepted:
15
01
2024
medline:
9
8
2024
pubmed:
9
8
2024
entrez:
9
8
2024
Statut:
epublish
Résumé
Mobile apps provide a unique platform for mental health assessment and monitoring. They can provide real time, accessible data on symptoms of mental disorders that may yield rich data for detailed clinical assessment and help individuals gain insight into their current mental state. We developed one of the first apps for tracking symptoms of prolonged grief disorder. In this pilot feasibility study, we assess the feasibility and acceptability of a new mobile app mGAGE for use once a day for 3 weeks. 27 participants completed mental health assessments at t1 and t2. Adherence to the app protocol was very high with 100% for the first two weeks of use. A surprising finding was the improvement of grief symptoms at t2. Debriefing interviews revealed general qualitative categories including positive feedback, negative feedback and specific recommendations. Overall, the app was found to be feasible for use for the first two weeks and acceptable for bereaved individuals. This app could provide valuable data for in depth clinical assessment, may support individuals to gain greater insight into their symptoms and may have a therapeutic effect in terms of improved grief symptoms. Implications for future studies including use in larger intervention studies are discussed.
Sections du résumé
Background
UNASSIGNED
Mobile apps provide a unique platform for mental health assessment and monitoring. They can provide real time, accessible data on symptoms of mental disorders that may yield rich data for detailed clinical assessment and help individuals gain insight into their current mental state. We developed one of the first apps for tracking symptoms of prolonged grief disorder.
Method
UNASSIGNED
In this pilot feasibility study, we assess the feasibility and acceptability of a new mobile app mGAGE for use once a day for 3 weeks. 27 participants completed mental health assessments at t1 and t2.
Results
UNASSIGNED
Adherence to the app protocol was very high with 100% for the first two weeks of use. A surprising finding was the improvement of grief symptoms at t2. Debriefing interviews revealed general qualitative categories including positive feedback, negative feedback and specific recommendations. Overall, the app was found to be feasible for use for the first two weeks and acceptable for bereaved individuals.
Conclusions
UNASSIGNED
This app could provide valuable data for in depth clinical assessment, may support individuals to gain greater insight into their symptoms and may have a therapeutic effect in terms of improved grief symptoms. Implications for future studies including use in larger intervention studies are discussed.
Identifiants
pubmed: 39119221
doi: 10.32872/cpe.10881
pii: cpe.10881
pmc: PMC11303913
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e10881Déclaration de conflit d'intérêts
AA, CK, NG and AM report no conflict of interest. Taro Ueno is member of Japanese based startup company, SUSMED inc.